Skip to content

Bringing Precision Medicine to Market

  • June 10, 2019

When it comes to biopharmaceutical drug discovery and development, we live in an incredible time. The FDA has approved innovative medicines with differing approaches, platforms, technologies, and modalities. As we leverage new technologies, our strategies for drug discovery are leading to therapeutic diversity, which is rapidly becoming a complicated landscape for manufacturing teams.

In this eBook authored by Amit Bhatia, Anthony Reese, and Akhil Rachamadugu of Scimitar, Inc., learn how diverse therapies are creating complexity and how digital innovations are driving modernization in today’s biopharmaceutical landscape.

Topics covered:

  • Novel Technologies and Platforms
  • Every Patient is a “Batch”
  • What is Needed to Scale for Success?
  • Case Studies

 

RELATED NEWS

Executive Summits: Choosing 1-2-1 Quality Over Trade Show Floor Noise

In an era where digital noise is at an all-time high, the B2B landscape is witnessing a significant shift in how...

by Clarissa Wong

Cross-Functional Leadership in Manufacturing: How Enrique Porras of RPM is Maximizing Performance [Speaker Spotlight]

As operational demands intensify and the pressure to maximize performance grows, manufacturers must optimize every...

by Rihana Alladina